glp-1 agonists and fertility Medications Fertility: What the Science Says — Natalie Crawford MD The hidden impact of GLP‐1

Those fatty acids then signal cells in the intestinal tract to release GLP-1 into the bloodstream

Discontinuation of GLP-1 therapy may result in weight regain and recurrence of hepatic steatosis, emphasizing the need for long-term treatment strategies

Stacking with: DHEA for hormonal balance ZMT for sleep and recovery Probiotics for gut health Whey Protein Isolate for lean mass retention helps ensure results are sustainable and performance-driven

Guidelines provided by KDIGO similarly recommend SGLT2i for people with an eGFR of 30 ml/min/1.73 m 2 due to the vascular and renal benefit, despite its modest effect on glucose control [2]

CVOTs cardiovascular outcome trials, T2DM type 2 diabetes mellitus, GLP-1RAs GLP-1 receptor agonists, HbA1c glycated hemoglobin, ACS acute coronary syndrome, OAD oral antidiabetic drugs, eGFR estimated glomerular filtration rate, UACR urine albumin-creatinine ratio, CVD cardiovascular disease, BMI body mass index, T1DM type 1 diabetes mellitus, DPP-4i DPP-4 inhibitor, HR hazard ratio, CI confidence interval, HF heart failure Outside of those major clinical trials, a nationwide retrospective study in Taiwan, China, evaluated the effects of DPP-4i in elderly patients with T2DM relative to cardiovascular outcomes